Related Experiment Video
Updated: May 17, 2026

05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders
Alexander Engstrom1, James D Vasta2, Matthew B Robers2
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, 1156 High St., Santa Cruz, California 95064, United States.
Journal of Medicinal Chemistry
|May 15, 2026
Summary
Measuring proteolysis targeting chimeras (PROTACs) membrane permeability into living cells is now possible. This new NanoBRET method quantifies cytosolic access, revealing insights missed by traditional assays for better PROTAC design.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Membrane permeability is crucial for proteolysis targeting chimera (PROTAC) efficacy.
- Conventional assays like PAMPA and Caco-2 transwell assays have limitations in measuring cytosolic access.
Purpose of the Study:
- To develop and validate a novel method for directly measuring PROTAC membrane permeability into the cytosol of living cells.
- To overcome the limitations of existing assays in assessing real-time cytosolic entry.
Main Methods:
- Utilized NanoBRET (BRET) live-cell target engagement technology.
- Quantified real-time membrane permeability rates of PROTACs and E3 ligase ligands.
- Compared results with traditional transwell assay data.
Main Results:
- The NanoBRET method accurately quantified permeability rates comparable to transwell systems.
- Identified and quantified permeability rates for PROTACs previously undetectable in transwell assays.
- Revealed differential permeabilities for BET-targeting PROTACs with subtle structural modifications, correlating with degradation efficiency and cytotoxicity.
Conclusions:
- The developed NanoBRET-based method enables direct, quantitative measurement of PROTAC membrane permeability into living cell cytosol.
- This approach overcomes limitations of traditional assays, providing a powerful tool for PROTAC design and optimization.
- Facilitates the study of previously unmeasurable PROTACs, aiding in understanding structure-activity relationships and improving drug development.

